Response Inhibition Training for Obsessive-Compulsive Disorder
(OCRD Trial)
Trial Summary
The trial requires that you do not change your psychotropic medication status within 8 weeks before or during the study. If you are on stimulant medication, you may need to stop taking it to participate.
Research suggests that combining computerized cognitive training with traditional therapy methods like exposure and response prevention (ERP) can improve treatment outcomes for obsessive-compulsive disorder (OCD). Additionally, computer-assisted therapy has been shown to be effective and can reduce the need for therapist contact, making it a promising option for OCD treatment.
12345Computerized cognitive training, which includes response inhibition training, is considered safe for various conditions, including depression and ADHD, according to existing research.
678910Response Inhibition Training is unique because it uses computerized cognitive exercises to help improve self-control and reduce compulsive behaviors, offering a potentially more accessible and cost-effective option compared to traditional therapy that requires regular therapist contact.
124511Eligibility Criteria
This trial is for adults aged 18-60 with moderate to severe obsessive-compulsive or related disorders (OCRD), such as OCD, trichotillomania, or skin picking disorder. Participants should have certain levels of symptoms measured by specific scales and a deficit in response inhibition. They must not have psychotic disorders, bipolar disorder, schizophrenia, high suicide risk, MRI contraindications, substance use issues, severe ADHD or recent changes in psychotropic meds.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase I
Participants undergo 8 to 16 sessions of computerized Response Inhibition Training (RIT) or placebo training, with neurobehavioral measures taken pre- and post-training.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data collected on functional outcomes.
Treatment Phase II
Similar to Phase I, participants undergo additional sessions of RIT or placebo training, focusing on reduction in OCRD symptoms.